June 20, 2012
A Delaware federal judge ruled Monday that Boston Scientific Corp.'s drug-eluting Promus stents don't infringe three patents held by Johnson & Johnson subsidiary Cordis Corp., the latest victory for Boston Scientific in its "Stent Wars" with J&J.